Association between ATM rs1801516 polymorphism and cancer susceptibility: a meta-analysis involving 12,879 cases and 18,054 controls

Gu, Yulu; Shi, Jikang; Qiu, Shuang; Qiao, Yichun; Zhang, Xin; Cheng, Yi; Liu, Yawen

doi:10.1186/s12885-018-4941-1

Table 1 Main characteristics of the eligible studies included in the meta-analysis

From: Association between ATM rs1801516 polymorphism and cancer susceptibility: a meta-analysis involving 12,879 cases and 18,054 controls

First author	Year	Country	Region-specified population	Cancer type	Source of controls	Matched controls	Family history	N		NOS Score
First author	Year	Country	Region-specified population	Cancer type	Source of controls	Matched controls	Family history	Cases	Controls	NOS Score
Maillet P [45]	2000	Swiss	European	Colorectal cancer	PBC	No	Yes	47	163	7
Dork T [34]	2001	Germany	European	Breast cancer	PBC	Yes	No	1000	500	8
Sommer SS [17]	2002	USA	North American	Breast cancer	HBC	Yes	No	43	43	7
Angele S [33]	2003	France	European	Breast cancer	PBC	Yes	No	254	312	8
Bretsky P [22]	2003	USA	North American	Breast cancer	PBC	Yes	No	428	426	9
Angele S [53]	2004	UK	European	Prostate cancer	PBC	No	No	637	445	7
Buchholz TA [37]	2004	USA	North American	Breast cancer	PBC	No	No	58	528	7
Kristensen AT [46]	2004	Norway	European	Colorectal cancer	PBC	No	No	151	3526	7
Heikkinen K [35]	2005	Finland	European	Breast cancer	PBC	Yes	Yes	121	306	9
Landi S [47]	2006	Six countries^c	European	Lung cancer	HBC	Yes	No	299	317	8
Renwick A [36]	2006	UK	European	Breast cancer	PBC	No	Yes	443	521	7
Tommiska J ^a [29]	2006	Finland	European	Breast cancer	NR	Yes	Yes	786	708	7
Tommiska J ^b [29]	2006	Finland	European	Breast cancer	NR	Yes	No	884	708	7
Wu X [48]	2006	USA	North American	Bladder cancer	HBC	Yes	No	696	629	8
Yang H [21]	2007	USA	North American	Lung cancer	HBC	Yes	No	556	556	8
Gonzalez-Hormazabal P [18]	2008	Chile	South America	Breast cancer	HBC	Yes	Yes	126	200	8
Hirsch AE [23]	2008	USA	North American	Breast cancer	HBC	Yes	No	37	95	7
Margulis V [54]	2008	USA	North American	Renal cell cancer	PBC	Yes	No	326	335	9
Schrauder M [32]	2008	Germany	European	Breast cancer	HBC	Yes	No	514	511	8
Tapia T [31]	2008	Chile	South America	Breast cancer	PBC	No	Yes	95	200	7
Akulevich NM ^a [30]	2009	Russian, Belarus	European	Thyroid cancer	PBC	Yes	No	123	198	9
Akulevich NM ^b [30]	2009	Russia	European	Thyroid cancer	PBC	Yes	No	132	398	9
Li D [52]	2009	USA	North American	Pancreatic cancer	HBC	Yes	No	734	780	8
Oliveira S [43]	2011	Portuguese	European	Cervical cancer	HBC	No	No	149	280	6
Al-Hadyan KS [49]	2012	Saudi Arabia	Asian	Head and neck cancer	NR	No	No	156	251	6
Xu L ^a [24]	2012	USA	North American	Thyroid cancer	HBC	No	No	303	511	6
Xu L ^b [24]	2012	USA	North American	Thyroid cancer	PBC	Yes	No	289	374	9
Alsbeih G [42]	2013	Saudi Arabia	Asian	Cervical cancer	NR	Yes	No	100	100	8
Pena-Chilet M [50]	2013	Spanish	European	Malignant melanoma	HBC	Yes	No	566	347	7
Calderon-Zuniga Fdel C [20]	2014	Mexico	North American	Breast cancer	HBC	No	Yes	94	96	6
Damiola F [39]	2014	Belarus	European	Thyroid cancer	PBC	Yes	No	83	324	9
Wojcicka A [38]	2014	Poland	European	Thyroid cancer	HBC	No	No	1603	1844	6
Maillard S [19]	2015	France	Oceanian	Thyroid cancer	PBC	Yes	No	177	275	9
Pereda CM [41]	2015	Cuba	North American	Thyroid cancer	PBC	Yes	No	203	212	9
Tecza K [51]	2015	Poland	European	Ovarian cancer	HBC	Yes	No	225	348	7
Halkova T [40]	2016	Czech Republic	European	Thyroid cancer	NR	No	No	209	374	6
Al-Harbi NM [44]	2017	Saudi Arabia	Asian	Cervical cancer	NR	Yes	No	232	313	7

HBC, hospital-based case–controls; PBC, population-based case–controls; NR, not report
^a,b Two independent case-control studies were presented for the same original study
^cThis study was conducted in six Central and Eastern European countries: Czech Republic, Hungary, Poland, Romania, Russia, and Slovakia

Back to article page

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com

BMC Cancer

Contact us